News & Media

17 August 2026

High-grade serous ovarian cancer (HGSOC) is the most common and one of the most aggressive forms of ovarian cancer. With...

12 August 2026

Our cells have built-in safeguards that help the immune system distinguish the body’s own RNA from foreign RNA, such a...

7 August 2026

Cancer cells change how they use sugar to support their rapid growth. Using yeast as a laboratory model, researchers fou...

15 July 2026

The N2CR Poster Day & Networking Session held on 7 July 2026 brought together the N2CR community for an inspiring ...

2 July 2026

Dr Alan Prem Kumar and his team have discovered a key protein called DP103 that acts like a “master switch,” helping...

8 June 2026

Researchers at N2CR have discovered that brief exposure to magnetic fields can reprogramme the immune landscape of solid...

18 May 2026

Dr Melissa Ooi, our theme lead for SCOUT, shares her passion for health services research. She reflects on how her work ...

29 April 2026

Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. About 30% of patients do not respond well to the ...

23 April 2026

The LARA trial, led by Assoc Prof David Tan and Dr Natalie Ngoi, marks a major step forward in tackling clear cell gynae...